Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2007
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/20/2007US7297798 Process for the preparation of the insecticide imidacloprid
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297727 Antifouling marine paints; terpolymers containing units of triphenylsilyl (meth)acrylate
11/20/2007US7297711 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/20/2007US7297706 Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297695 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/20/2007US7297694 central nervous system disorders; traumas; anticancer agents; neurodegenerative agents; analgesics; headaches and cardiovascular disorders
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007US7297555 Amine-reactive quaternary acridinium compounds, e.g., pentafluorophenyloxy-1-carbonyl-4,7,10,13-tetraoxapentadecyl-(15-amino)-3'-sulfonyl-2',6'-dimethylphenyl-N-(3-sulfopropyl)-acridinium-9-carboxylate with increased solubility; chemiluminescent conjugates, especially with antibodies; assay kits
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131179A1 Factor xa inhibitors
11/15/2007WO2007130822A2 Mglur5 modulators iii
11/15/2007WO2007130821A2 Mglur5 modulators ii
11/15/2007WO2007130780A2 Benzimidazole modulators of vr1
11/15/2007WO2007130712A1 Substituted dipiperidine as ccr2 antagonists for the treatment of inflammatory diseases
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129066A1 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
11/15/2007WO2007129052A1 Pyrazole derivatives and their use as pi3k inhibitors
11/15/2007WO2007129036A1 Inhibitors of p38 map kinase
11/15/2007WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
11/15/2007WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128568A1 Bicyclic derivatives as cetp inhibitors
11/15/2007WO2007128460A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
11/15/2007WO2007128086A2 Novel viral replication inhibitor
11/15/2007WO2007128059A1 Bis-pyridinium compounds
11/15/2007WO2007110340A3 Pyrimidine, quinazoline, pteridine and triazine derivatives
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007108743A3 Novel quinazolines as 5-ht6 modulators ii
11/15/2007WO2007099323A3 Quinoline derivatives
11/15/2007WO2007094858A3 Process for amination of acrylic macromonomers and products therefrom
11/15/2007WO2007090579A3 Substituted quinolones iii
11/15/2007WO2007089678A3 Potassium channel inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007075650A3 Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
11/15/2007WO2007067836A3 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
11/15/2007WO2004032856A3 Compounds
11/15/2007WO2002089799A3 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/15/2007US20070265447 Process for the Preparation of Ziprasidone (5-[2-[4-(1,2-Benziosothiazol-3-Y1)-1-Piperazinyl]Ethyl]-6-Chloro-1,3-Dihydro-2H-Indol-2- One
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265325 Nitro Indazole Derivatives
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265311 Therapeutic Salt Compositions and Methods
11/15/2007US20070265310 Biphenyl compounds useful as muscarinic receptor antagonists
11/15/2007US20070265308 5-[5-(2-chloro-4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-4-yl]-1-(2,6-dichlorophenyl)pyridin-2(1H)-one; p38 MAP kinase inhibitory activity; inflammatory, respiratory , circulatory and central nervous diseases; rheumatoid arthritis
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265300 Pyridine Derivatives of Alkyl Oxindoles as 5-Ht7 Receptor Active Agents
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265292 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; anticarcinogenic and antproliferative agent; angiogenesis inhibitor
11/15/2007US20070265290 Male contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia; prostate cancer
11/15/2007US20070265289 2-Aminopyrimidine Derivative
11/15/2007US20070265288 Stable Crystal Form of Imatinib Mesylate and Process for the Preparation Thereof
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265279 Use of mGluR5 antagonists for the treatment of pruritic conditions
11/15/2007US20070265278 2-phenyl-indoles as prostaglandin d2 receptor antagonists
11/15/2007US20070265274 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-ret kinase associated diseases
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265262 viricides selecting from a group of compounds, carbamoyl-pyrrolidine-1-carboxylic acid benzyl ester derivatives; treating or preventing a viral infection; 2-(2',4'-Dimethoxy-biphenyl-4-ylcarbamoyl)-pyrrolidine-1-carboxylic acid benzyl ester
11/15/2007US20070265261 Dpp-IV Inhibitors
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070264299 contain 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-pyrazole-5-carboxamide; for controlling invertebrate pests in both agronomic and nonagronomic environments
11/15/2007CA2651303A1 Factor xa inhibitors
11/15/2007CA2651152A1 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
11/15/2007CA2651128A1 Benzimidazole modulators of vr1
11/15/2007CA2650976A1 Bicyclic heteroaryl compounds as pde10 inhibitors
11/15/2007CA2650954A1 Bicyclic derivatives as cetp inhibitors
11/15/2007CA2650553A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
11/15/2007CA2650114A1 Mglur5 modulators i
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/15/2007CA2589021A1 Crystalline imatinib base and production process therefor
11/14/2007EP1854792A1 1-(2h)-isoquinolone derivative
11/14/2007EP1854789A1 Quinazoline derivative having tyrosine kinase inhibitory activity
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1853602A1 Chemical compounds
11/14/2007EP1853600A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853589A1 Process for preparing 2,3-disubstituted indoles
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853586A1 Antibacterial piperidine derivatives
11/14/2007EP1853585A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
11/14/2007EP1853584A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853582A2 Heterocyclylamide-substituted imidazoles
11/14/2007EP1853581A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
11/14/2007EP1853580A1 Methylphenylcarbamic acid 5-(4-isobutyl-2,6,-dioxopiperazin-1-yl)pyridinyl-2-yl ester and salts as hormone sensitive lipase inhibitors
11/14/2007EP1853260A1 Substituted pyrazoles as modulators of chemokine receptors
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 1080